Table 3.

Sensitivity Analysis Hazard Ratio Point Estimates

Covariate	N Unexposed	N Psoriasis	Model Hazard Ratio (95% CI)
Primary analysis	14,330	3,603	1.53(1.26, 1.85)
Inclusion of patients with at least 1 GP visit per year on average	13,643	3,563	1.50(1.23, 1.81)
Primary model with exclusion of methotrexate	13,289	1,358	1.86(1.44,2.41)
Primary model with exclusion of oral retinoids or cyclosporine	13,253	2,653	1.42(1.14, 1.77)
Primary model restricted to patients who received oral retinoids	13,253	303	1.56(1.05,2.32)
Primary model with exclusion of psoriatic arthritis	13,289	1,156	1.44(1.16, 1.78)
Inclusion of patients with at least 6 months of person time	11,832	2,963	1.60(1.32, 1.95)
Primary model with BMI included*	9,870	2,433	1.71 (1.32,2.18)
Primary model without BMI included in those who had BMI measured*	9,870	2,433	1.70(1.32,2.17)

^*BMI is included in n=12,303 or 69% of patients.

Abbreviations: BMI, body mass index; CI, confidence interval; GP, general practitioner; TIA, transient ischemic attack.